This week on Front Line News, we learn about one of the most promising #COVID19 vaccines to date. A vaccine by Maryland based Novavax is being tested in a phase three trial at the University of Maryland. And a groundbreaking study on the lifelong effects of high cholesterol.
The University of Maryland School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond.
source
